标题
Targeting B Cells and Plasma Cells in Autoimmune Diseases
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-23
DOI
10.3389/fimmu.2018.00835
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- B cells and their cytokine activities implications in human diseases
- (2018) Simon Fillatreau CLINICAL IMMUNOLOGY
- Belimumab: A Review in Systemic Lupus Erythematosus
- (2018) Hannah A. Blair et al. DRUGS
- Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini–Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
- (2018) Elias Jabbour et al. JAMA Oncology
- The discovery of plasma cells: An historical note
- (2017) Domenico Ribatti IMMUNOLOGY LETTERS
- Human regulatory B cells in health and disease: therapeutic potential
- (2017) Claudia Mauri et al. JOURNAL OF CLINICAL INVESTIGATION
- Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy
- (2017) Qiming Wang et al. JOURNAL OF IMMUNOLOGY
- Induction and Differentiation of IL-10–Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients
- (2017) Zsuzsanna Bankó et al. JOURNAL OF IMMUNOLOGY
- Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients
- (2017) Elena Giacomini et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- Antinuclear antibody testing — misunderstood or misbegotten?
- (2017) David S. Pisetsky Nature Reviews Rheumatology
- Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
- (2017) Michaela Seeling et al. Nature Reviews Rheumatology
- Memory B cell resurgence requires repeated rituximab in myasthenia gravis
- (2017) Kohei Muto et al. NEUROMUSCULAR DISORDERS
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial
- (2017) Seerapani Gopaluni et al. Trials
- Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins
- (2017) Venkat Reddy et al. ARTHRITIS CARE & RESEARCH
- Current perspective on rituximab in rheumatic diseases
- (2017) Tommaso Schioppo et al. Drug Design Development and Therapy
- Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients
- (2017) Elena Giacomini et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
- (2017) Eleonore Fröhlich et al. Frontiers in Immunology
- Chronic Exposure to Malaria Is Associated with Inhibitory and Activation Markers on Atypical Memory B Cells and Marginal Zone-Like B Cells
- (2017) Itziar Ubillos et al. Frontiers in Immunology
- Mechanisms of Autoantibody-Induced Pathology
- (2017) Ralf J. Ludwig et al. Frontiers in Immunology
- Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
- (2017) Michael J. E. Marshall et al. Frontiers in Immunology
- Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus
- (2016) Qian Zhao et al. CLINICAL DRUG INVESTIGATION
- A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins
- (2016) A.S. Rosenberg et al. CLINICAL IMMUNOLOGY
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus
- (2016) Madhvi Menon et al. IMMUNITY
- Control of memory B cell responses by extrinsic and intrinsic mechanisms
- (2016) Jürgen Wienands et al. IMMUNOLOGY LETTERS
- IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration
- (2016) Upasana Kulkarni et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Germinal center B cells recognize antigen through a specialized immune synapse architecture
- (2016) Carla R Nowosad et al. NATURE IMMUNOLOGY
- Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- (2016) René Pfeifle et al. NATURE IMMUNOLOGY
- Plasma cells as an innovative target in autoimmune disease with renal manifestations
- (2016) Falk Hiepe et al. Nature Reviews Nephrology
- Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells
- (2016) Sarantis Korniotis et al. Nature Communications
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- Expansion of B-1a Cells with Germline Heavy Chain Sequence in Lupus Mice
- (2016) Nichol E. Holodick et al. Frontiers in Immunology
- Excessive Cytosolic DNA Fragments as a Potential Trigger of Graves’ Disease: An Encrypted Message Sent by Animal Models
- (2016) Yuqian Luo et al. Frontiers in Endocrinology
- Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice
- (2015) Shang-xue Yan et al. ACTA PHARMACOLOGICA SINICA
- Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study
- (2015) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
- (2015) A. de Masson et al. BLOOD
- Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases
- (2015) Charles E. Egwuagu et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases
- (2015) Andreia C. Lino et al. IMMUNOLOGICAL REVIEWS
- Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research
- (2015) Tomomitsu Miyagaki et al. INTERNATIONAL IMMUNOLOGY
- The expanding family of regulatory B cells
- (2015) Claudia Mauri et al. INTERNATIONAL IMMUNOLOGY
- Refractory Primary Sjögren Syndrome Successfully Treated With Bortezomib
- (2015) Juan Jakez-Ocampo et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Complexity of the human memory B-cell compartment is determined by the versatility of clonal diversification in germinal centers
- (2015) Bettina Budeus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions
- (2015) Marc Seifert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
- (2015) Takashi Matsushita et al. RHEUMATOLOGY
- Plasmazellen
- (2015) F. Hiepe et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors
- (2015) Adriano Taddeo et al. ARTHRITIS RESEARCH & THERAPY
- Proteasome inhibitors as experimental therapeutics of autoimmune diseases
- (2015) Sue Verbrugge et al. ARTHRITIS RESEARCH & THERAPY
- The Interplay Between Monocytes/Macrophages and CD4+ T Cell Subsets in Rheumatoid Arthritis
- (2015) Ceri A. Roberts et al. Frontiers in Immunology
- B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
- (2015) Nele Claes et al. Frontiers in Immunology
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
- (2014) P Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Bortezomib for Refractory Autoimmunity in Pediatrics
- (2014) Pooja Khandelwal et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impaired function of CD19+CD24hiCD38hiregulatory B cells in patients with pemphigus
- (2014) H.-Q. Zhu et al. BRITISH JOURNAL OF DERMATOLOGY
- From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets
- (2014) Van Duc Dang et al. CURRENT OPINION IN IMMUNOLOGY
- Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts
- (2014) Guido Heine et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
- (2014) Masanori Matsumoto et al. IMMUNITY
- High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis
- (2014) Anaïs Gardette et al. JOINT BONE SPINE
- Longterm Followup of Rituximab Therapy in Patients with Rheumatoid Arthritis: Results from the Belgian MabThera in Rheumatoid Arthritis Registry
- (2014) F. De Keyser et al. JOURNAL OF RHEUMATOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- IgG1 protects against renal disease in a mouse model of cryoglobulinaemia
- (2014) Richard T. Strait et al. NATURE
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production
- (2014) Elizabeth C Rosser et al. NATURE MEDICINE
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant
- (2014) Bhakti Mehta et al. PEDIATRIC BLOOD & CANCER
- Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
- (2014) Paul Emery et al. PLoS One
- Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report
- (2014) Sean Yates et al. TRANSFUSION
- A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis
- (2014) Maria Greenwald et al. ARTHRITIS RESEARCH & THERAPY
- Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease Activity
- (2014) Claire I. Daien et al. Arthritis & Rheumatology
- Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis
- (2014) Stephanie Glaesener et al. Arthritis & Rheumatology
- Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis
- (2014) Jeremy Sokolove et al. Arthritis & Rheumatology
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response
- (2013) J. Mélet et al. ARTHRITIS AND RHEUMATISM
- ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review
- (2013) Petar Lenert et al. CLINICAL RHEUMATOLOGY
- Genome-wide association studies to advance our understanding of critical cell types and pathways in rheumatoid arthritis
- (2013) Dorothée Diogo et al. CURRENT OPINION IN RHEUMATOLOGY
- Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib
- (2013) Tessa van Balen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies
- (2013) Mattias Collin et al. EXPERIMENTAL DERMATOLOGY
- The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
- (2013) G. Cambridge et al. JOURNAL OF AUTOIMMUNITY
- T cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies
- (2013) Constanze Hess et al. JOURNAL OF CLINICAL INVESTIGATION
- Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells
- (2013) Elissa K. Deenick et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
- (2013) W. Stohl et al. JOURNAL OF RHEUMATOLOGY
- Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
- (2013) E. M. Ginzler et al. JOURNAL OF RHEUMATOLOGY
- Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis
- (2013) Feng Sun et al. MUSCLE & NERVE
- Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells
- (2013) Daniela A Bermejo et al. NATURE IMMUNOLOGY
- Humoral Pattern Recognition and the Complement System
- (2013) S. E. Degn et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
- (2013) F. Flores-Borja et al. Science Translational Medicine
- Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
- (2013) N. Colliou et al. Science Translational Medicine
- B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
- (2013) Maria J Leandro ARTHRITIS RESEARCH & THERAPY
- Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
- (2012) Alejandro M. Gomez et al. Annals of the New York Academy of Sciences
- Immune Regulatory Function of B Cells
- (2012) Claudia Mauri et al. Annual Review of Immunology
- Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
- (2012) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Tolerance induction with T cell–dependent protein antigens induces regulatory sialylated IgGs
- (2012) Carolin M. Oefner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: IL-21 Derived from Human Follicular Helper T Cells Acts as a Survival Factor for Secondary Lymphoid Organ, but Not for Bone Marrow, Plasma Cells
- (2012) B. Rodriguez-Bayona et al. JOURNAL OF IMMUNOLOGY
- The Skin, a Novel Niche for Recirculating B Cells
- (2012) S. A. Geherin et al. JOURNAL OF IMMUNOLOGY
- CD19 as an attractive target for antibody-based therapy
- (2012) Ohad Hammer mAbs
- Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1
- (2012) Christian M Karsten et al. NATURE MEDICINE
- Schistosomes Induce Regulatory Features in Human and Mouse CD1dhi B Cells: Inhibition of Allergic Inflammation by IL-10 and Regulatory T Cells
- (2012) Luciën E. P. M. van der Vlugt et al. PLoS One
- Innate Response Activator B Cells Protect Against Microbial Sepsis
- (2012) P. J. Rauch et al. SCIENCE
- Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
- (2012) M. Couderc et al. ARTHRITIS CARE & RESEARCH
- Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity
- (2012) YK Onno Teng et al. ARTHRITIS RESEARCH & THERAPY
- Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
- (2012) Henrik E Mei et al. ARTHRITIS RESEARCH & THERAPY
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- Protective Roles of Natural IgM Antibodies
- (2012) Caroline Grönwall et al. Frontiers in Immunology
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
- (2011) K. Chatzidionysiou et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment
- (2011) Preeti Lal et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- BAFF inhibition: A new class of drugs for the treatment of autoimmunity
- (2011) Zheng Liu et al. EXPERIMENTAL CELL RESEARCH
- Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis
- (2011) A. M. Gomez et al. JOURNAL OF IMMUNOLOGY
- Regulatory B10 Cells Differentiate into Antibody-Secreting Cells After Transient IL-10 Production In Vivo
- (2011) D. Maseda et al. JOURNAL OF IMMUNOLOGY
- Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission
- (2011) Stephanie Knippenberg et al. JOURNAL OF NEUROIMMUNOLOGY
- Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
- (2011) BOULOS HARAOUI et al. JOURNAL OF RHEUMATOLOGY
- Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies-Induced Glomerulonephritis
- (2011) J. Bontscho et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Successful treatment of IgG and complement-mediated autoimmune hemolytic anemia with bortezomib and low-dose cyclophosphamide
- (2010) Pongwut Danchaivijitr et al. AMERICAN JOURNAL OF HEMATOLOGY
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis
- (2010) Altan Ercan et al. ARTHRITIS AND RHEUMATISM
- Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?
- (2010) Maurizio Benucci et al. AUTOIMMUNITY REVIEWS
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Human peripheral blood B-cell compartments: A crossroad in B-cell traffic
- (2010) M. Perez-Andres et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
- (2010) Sudhanshu Agrawal et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs
- (2010) Robert M. Anthony et al. JOURNAL OF CLINICAL IMMUNOLOGY
- TLR and B Cell Receptor Signals to B Cells Differentially Program Primary and Memory Th1 Responses to Salmonella enterica
- (2010) T. A. Barr et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
- (2010) A. Rubbert-Roth et al. RHEUMATOLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients
- (2009) Tim Y.-T. Lu et al. ARTHRITIS AND RHEUMATISM
- Depletion of functionally active CD20+ T cells by rituximab treatment
- (2009) Esther Wilk et al. ARTHRITIS AND RHEUMATISM
- Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study
- (2009) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Anti-CD20 monoclonal antibodies: historical and future perspectives
- (2009) S. H. Lim et al. HAEMATOLOGICA
- Multiple layers of B cell memory with different effector functions
- (2009) Ismail Dogan et al. NATURE IMMUNOLOGY
- Regulatory T cells as therapeutic targets in rheumatoid arthritis
- (2009) Jonathan H. Esensten et al. Nature Reviews Rheumatology
- CD19: a promising B cell target for rheumatoid arthritis
- (2009) Thomas F. Tedder Nature Reviews Rheumatology
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- (2008) D Albert et al. ANNALS OF THE RHEUMATIC DISEASES
- Peripheral B cell subsets
- (2008) David Allman et al. CURRENT OPINION IN IMMUNOLOGY
- Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab
- (2008) Martin Pfütze et al. DERMATOLOGY
- Complement and cellular cytotoxicity in antibody therapy of cancer
- (2008) Siao-Yi Wang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- Induction of Cytosolic Calcium Flux by CD20 Is Dependent upon B Cell Antigen Receptor Signaling
- (2008) Claire A. Walshe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activated B cells in autoimmune diseases: the case for a regulatory role
- (2008) Stephen M Anderton et al. Nature clinical practice. Rheumatology
- Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab
- (2007) Alastair J. Ferraro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started